Skip to main content
Top
Published in: European Journal of Nuclear Medicine and Molecular Imaging 6/2005

01-06-2005 | Original Article

Occult lung infarction may induce false interpretation of 18F-FDG PET in primary staging of pulmonary malignancies

Authors: Ehab M. Kamel, Thomas A. Mckee, Maria-Lucia Calcagni, Sabine Schmidt, Serge Markl, Sandra Castaldo, Angelika Bischof Delaloye

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 6/2005

Login to get access

Abstract

Purpose

The aim of the present report is to describe abnormal 18F-fluorodeoxyglucose (FDG) accumulation patterns in the pleura and lung parenchyma in a group of lung cancer patients in whom lung infarction was present at the time of positron emission tomography (PET).

Methods

Between November 2002 and December 2003, a total of 145 patients (102 males, 43 females; age range 38–85 years) were subjected to whole-body FDG PET for initial staging (n=117) or restaging (n=11) of lung cancer or for evaluation of solitary pulmonary nodules (n=17). Of these patients, 24 displayed abnormal FDG accumulation in the lung parenchyma that was not consistent with the primary lesion under investigation (ipsilateral n=12, contralateral n=9 or bilateral n=3). Without correlative imaging, this additional FDG uptake would have been considered indeterminate in differential diagnosis.

Results

Of the 24 patients who were identified as having such lesions, six harboured secondary tumour nodules diagnosed as metastases, while in three the diagnosis of a synchronous second primary lung tumour was established. Additionally, nine patients were identified as having post-stenotic pneumonia and/or atelectasis (n=6) or granulomatous lung disease (n=3). In the remaining six (4% of all patients), a diagnosis of recent pulmonary embolism that topographically matched the additional FDG accumulation (SUVmax range 1.4–8.6, mean 3.9) was made. Four of these six patients were known to have pulmonary embolism, and hence false positive interpretation was avoided by correlating the PET findings with those of the pre-existing diagnostic work-up. The remaining two patients were harbouring small occult infarctions that mimicked satellite nodules in the lung periphery. Based on histopathological results, the abnormal FDG accumulation in these two patients was attributed to the inflammatory reaction and tissue repair associated with the pathological cascade of pulmonary embolism.

Conclusion

In patients with pulmonary malignancies, synchronous lung infarction may induce pathological FDG accumulation that can mimic active tumour manifestations. Identifying this potential pitfall may allow avoidance of false positive FDG PET interpretation.
Literature
1.
go back to reference Verboom P, van Tinteren H, Hoekstra OS, Smit EF, van den Bergh JH, Schreurs AJ, et al. Cost-effectiveness of FDG-PET in staging non-small cell lung cancer: the PLUS study. Eur J Nucl Med Mol Imaging 2003;30:1444–9.CrossRef Verboom P, van Tinteren H, Hoekstra OS, Smit EF, van den Bergh JH, Schreurs AJ, et al. Cost-effectiveness of FDG-PET in staging non-small cell lung cancer: the PLUS study. Eur J Nucl Med Mol Imaging 2003;30:1444–9.CrossRef
2.
go back to reference Higashi K, Ueda Y, Matsunari I, Kodama Y, Ikeda R, Miura K, et al. 11C-acetate PET imaging of lung cancer: comparison with 18F-FDG PET and 99mTc-MIBI SPET. Eur J Nucl Med Mol Imaging 2004;31:13–21. Higashi K, Ueda Y, Matsunari I, Kodama Y, Ikeda R, Miura K, et al. 11C-acetate PET imaging of lung cancer: comparison with 18F-FDG PET and 99mTc-MIBI SPET. Eur J Nucl Med Mol Imaging 2004;31:13–21.
3.
go back to reference Kamel EM, Zwahlen D, Wyss MT, Stumpe KD, von Schulthess GK, Steinert HC. Whole-body 18F-FDG PET improves the management of patients with small cell lung cancer. J Nucl Med 2003;44:1911–7.PubMed Kamel EM, Zwahlen D, Wyss MT, Stumpe KD, von Schulthess GK, Steinert HC. Whole-body 18F-FDG PET improves the management of patients with small cell lung cancer. J Nucl Med 2003;44:1911–7.PubMed
4.
go back to reference Fischer BM, Mortensen J, Dirksen A, Eigtved A, Hojgaard L. Positron emission tomography of incidentally detected small pulmonary nodules. Nucl Med Commun 2004;25:3–9. Fischer BM, Mortensen J, Dirksen A, Eigtved A, Hojgaard L. Positron emission tomography of incidentally detected small pulmonary nodules. Nucl Med Commun 2004;25:3–9.
5.
go back to reference Asad S, Aquino SL, Piyavisetpat N, Fischman AJ. False-positive FDG positron emission tomography uptake in nonmalignant chest abnormalities. AJR Am J Roentgenol 2004;182:983–9. Asad S, Aquino SL, Piyavisetpat N, Fischman AJ. False-positive FDG positron emission tomography uptake in nonmalignant chest abnormalities. AJR Am J Roentgenol 2004;182:983–9.
6.
go back to reference Mountain CF. The international system for staging lung cancer. Semin Surg Oncol 2000;18:106–15. Mountain CF. The international system for staging lung cancer. Semin Surg Oncol 2000;18:106–15.
7.
go back to reference Carretta A, Ciriaco P, Canneto B, Nicoletti R, Del Maschio A, Zannini P. Therapeutic strategy in patients with non-small cell lung cancer associated to satellite pulmonary nodules. Eur J Cardiothorac Surg 2002;21:1100–4. Carretta A, Ciriaco P, Canneto B, Nicoletti R, Del Maschio A, Zannini P. Therapeutic strategy in patients with non-small cell lung cancer associated to satellite pulmonary nodules. Eur J Cardiothorac Surg 2002;21:1100–4.
8.
go back to reference Costa DC, Visvikis D, Crosdale I, Pigden I, Townsend C, Bomanji J, et al. Positron emission and computed X-ray tomography: a coming together. Nucl Med Commun 2003;24:351–8. Costa DC, Visvikis D, Crosdale I, Pigden I, Townsend C, Bomanji J, et al. Positron emission and computed X-ray tomography: a coming together. Nucl Med Commun 2003;24:351–8.
9.
go back to reference Lardinois D, Weder W, Hany TF, Kamel EM, Korom S, Seifert B, et al. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med 2003;348:2500–7.CrossRefPubMed Lardinois D, Weder W, Hany TF, Kamel EM, Korom S, Seifert B, et al. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med 2003;348:2500–7.CrossRefPubMed
10.
go back to reference Barghouth G, Yersin B, Boubaker A, Doenz F, Schnyder P, Delaloye AB. Combination of clinical and V/Q scan assessment for the diagnosis of pulmonary embolism: a 2-year outcome prospective study. Eur J Nucl Med Mol Imaging 2000;27:1280–5. Barghouth G, Yersin B, Boubaker A, Doenz F, Schnyder P, Delaloye AB. Combination of clinical and V/Q scan assessment for the diagnosis of pulmonary embolism: a 2-year outcome prospective study. Eur J Nucl Med Mol Imaging 2000;27:1280–5.
11.
go back to reference Goldhaber SZ. Pulmonary embolism. Lancet 2004;363:1295–305. Goldhaber SZ. Pulmonary embolism. Lancet 2004;363:1295–305.
12.
go back to reference Guadagni F, Ferroni P, Basili S, Facciolo F, Carlini S, Crecco M, et al. Correlation between tumor necrosis factor-alpha and D-dimer levels in non-small cell lung cancer patients. Lung Cancer 2004;44:303–10. Guadagni F, Ferroni P, Basili S, Facciolo F, Carlini S, Crecco M, et al. Correlation between tumor necrosis factor-alpha and D-dimer levels in non-small cell lung cancer patients. Lung Cancer 2004;44:303–10.
13.
go back to reference Fedullo PF, Tapson VF. Clinical practice. The evaluation of suspected pulmonary embolism. N Engl J Med 2003;349:1247–56.CrossRefPubMed Fedullo PF, Tapson VF. Clinical practice. The evaluation of suspected pulmonary embolism. N Engl J Med 2003;349:1247–56.CrossRefPubMed
14.
go back to reference Hany TF, Heuberger J, von Schulthess GK. Iatrogenic FDG foci in the lungs: a pitfall of PET image interpretation. Eur Radiol 2003;13:2122–7. Hany TF, Heuberger J, von Schulthess GK. Iatrogenic FDG foci in the lungs: a pitfall of PET image interpretation. Eur Radiol 2003;13:2122–7.
15.
go back to reference Miceli M, Atoui R, Walker R, Mahfouz T, Mirza N, Diaz J, et al. Diagnosis of deep septic thrombophlebitis in cancer patients by fluorine-18 fluorodeoxyglucose positron emission tomography scanning: a preliminary report. J Clin Oncol 2004;22:1949–56. Miceli M, Atoui R, Walker R, Mahfouz T, Mirza N, Diaz J, et al. Diagnosis of deep septic thrombophlebitis in cancer patients by fluorine-18 fluorodeoxyglucose positron emission tomography scanning: a preliminary report. J Clin Oncol 2004;22:1949–56.
16.
go back to reference Osaki T, Sugio K, Hanagiri T, Takenoyama M, Yamashita T, Sugaya M, et al. Survival and prognostic factors of surgically resected T4 non-small cell lung cancer. Ann Thorac Surg 2003;75:1745–51.CrossRef Osaki T, Sugio K, Hanagiri T, Takenoyama M, Yamashita T, Sugaya M, et al. Survival and prognostic factors of surgically resected T4 non-small cell lung cancer. Ann Thorac Surg 2003;75:1745–51.CrossRef
17.
go back to reference Kjaer A, Lebech AM, Eigtved A, Hojgaard L. Fever of unknown origin: prospective comparison of diagnostic value of 18F-FDG PET and 111In-granulocyte scintigraphy. Eur J Nucl Med Mol Imaging 2004;31:622–6.CrossRefPubMed Kjaer A, Lebech AM, Eigtved A, Hojgaard L. Fever of unknown origin: prospective comparison of diagnostic value of 18F-FDG PET and 111In-granulocyte scintigraphy. Eur J Nucl Med Mol Imaging 2004;31:622–6.CrossRefPubMed
18.
go back to reference Bleeker-Rovers CP, de Kleijn EM, Corstens FH, van der Meer JW, Oyen WJ. Clinical value of FDG PET in patients with fever of unknown origin and patients suspected of focal infection or inflammation. Eur J Nucl Med Mol Imaging 2004;31:29–37.CrossRefPubMed Bleeker-Rovers CP, de Kleijn EM, Corstens FH, van der Meer JW, Oyen WJ. Clinical value of FDG PET in patients with fever of unknown origin and patients suspected of focal infection or inflammation. Eur J Nucl Med Mol Imaging 2004;31:29–37.CrossRefPubMed
19.
go back to reference Chen DL, Mintun MA, Schuster DP. Comparison of methods to quantitate 18F-FDG uptake with PET during experimental acute lung injury. J Nucl Med 2004;45:1583–90. Chen DL, Mintun MA, Schuster DP. Comparison of methods to quantitate 18F-FDG uptake with PET during experimental acute lung injury. J Nucl Med 2004;45:1583–90.
20.
go back to reference Kaim AH, Weber B, Kurrer MO, Westera G, Schweitzer A, Gottschalk J, et al. 18F-FDG and 18F-FET uptake in experimental soft tissue infection. Eur J Nucl Med Mol Imaging 2002;29:648–54.CrossRefPubMed Kaim AH, Weber B, Kurrer MO, Westera G, Schweitzer A, Gottschalk J, et al. 18F-FDG and 18F-FET uptake in experimental soft tissue infection. Eur J Nucl Med Mol Imaging 2002;29:648–54.CrossRefPubMed
21.
go back to reference Sorensen HT, Mellemkjaer L, Olsen JH, Baron JA. Prognosis of cancers associated with venous thromboembolism. N Engl J Med 2000;343:1846–50.CrossRefPubMed Sorensen HT, Mellemkjaer L, Olsen JH, Baron JA. Prognosis of cancers associated with venous thromboembolism. N Engl J Med 2000;343:1846–50.CrossRefPubMed
Metadata
Title
Occult lung infarction may induce false interpretation of 18F-FDG PET in primary staging of pulmonary malignancies
Authors
Ehab M. Kamel
Thomas A. Mckee
Maria-Lucia Calcagni
Sabine Schmidt
Serge Markl
Sandra Castaldo
Angelika Bischof Delaloye
Publication date
01-06-2005
Publisher
Springer-Verlag
Published in
European Journal of Nuclear Medicine and Molecular Imaging / Issue 6/2005
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-004-1718-3

Other articles of this Issue 6/2005

European Journal of Nuclear Medicine and Molecular Imaging 6/2005 Go to the issue